lncRNA-targeting candidate (HAYA Therapeutics)

N/A

Report date: 2025/03/20 15:46:32
NME

Base Information

Drug NamelncRNA-targeting candidate (HAYA Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHAYA Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesHAYA Therapeutics SA
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A